VSCPX
Price
$347.37
Change
-$0.00 (-0.00%)
Updated
Nov 7 closing price
WWSIX
Price
$30.85
Change
-$0.18 (-0.58%)
Updated
Nov 7 closing price
Ad is loading...

VSCPX vs WWSIX

Header iconVSCPX vs WWSIX Comparison
Open Charts VSCPX vs WWSIXBanner chart's image
Vanguard Small Cap Index InstlPlus
Price$347.37
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
TETON Westwood SmallCap Equity I
Price$30.85
Change-$0.18 (-0.58%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
VSCPX vs WWSIX Comparison Chart
Loading...
VS
VSCPX vs. WWSIX commentary
Nov 08, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is VSCPX is a StrongBuy and WWSIX is a StrongBuy.

FUNDAMENTALS
Fundamentals
VSCPX has more cash in the bank: 151B vs. WWSIX (67.1M). VSCPX pays higher dividends than WWSIX: VSCPX (1.44) vs WWSIX (0.85). VSCPX was incepted earlier than WWSIX: VSCPX (14 years) vs WWSIX (17 years). WWSIX is a more actively managed with annual turnover of: 17.00 vs. VSCPX (12.00). WWSIX has a lower initial minimum investment than VSCPX: WWSIX (500000) vs VSCPX (100000000). VSCPX (37.24) and WWSIX (35.60) have marching annual gain over last year. WWSIX (62.51) and VSCPX (59.59) have equivalent 5 years return.
VSCPXWWSIXVSCPX / WWSIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence14 years17 years-
Gain YTD18.06521.25885%
Front LoadN/AN/A-
Min. Initial Investment10000000050000020,000%
Min. Initial Investment IRAN/AN/A-
Net Assets151B67.1M225,037%
Annual Yield % from dividends1.440.85170%
Returns for 1 year37.2435.60105%
Returns for 3 years6.076.6891%
Returns for 5 years59.5962.5195%
Returns for 10 years127.5345.48280%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FIVN32.811.33
+4.22%
Five9
UROY2.820.10
+3.68%
Uranium Royalty Corp
BIDU93.532.61
+2.87%
Baidu
ANTX1.10N/A
N/A
AN2 Therapeutics
TGI15.33-0.40
-2.54%
Triumph Group